Capital Analysts LLC’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13K | Sell |
139
-6
| -4% | -$525 | ﹤0.01% | 1242 |
|
|
2026
Q1 | $12K | Buy |
145
+6
| +4% | +$535 | ﹤0.01% | 1219 |
|
|
2025
Q4 | $11K | Sell |
139
-125
| -47% | -$9.8K | ﹤0.01% | 1223 |
|
|
2025
Q3 | $21K | Hold |
264
| – | – | ﹤0.01% | 1063 |
|
|
2025
Q2 | $24K | Sell |
264
-138
| -34% | -$12.6K | ﹤0.01% | 972 |
|
|
2025
Q1 | $38K | Sell |
402
-137
| -25% | -$12.3K | ﹤0.01% | 851 |
|
|
2024
Q4 | $49K | Sell |
539
-27
| -5% | -$2.58K | ﹤0.01% | 750 |
|
|
2024
Q3 | $59K | Hold |
566
| – | – | ﹤0.01% | 684 |
|
|
2024
Q2 | $55K | Sell |
566
-173
| -23% | -$16K | ﹤0.01% | 688 |
|
|
2024
Q1 | $67K | Buy |
739
+1
| +0.1% | +$85 | ﹤0.01% | 602 |
|
|
2023
Q4 | $59K | Sell |
738
-38
| -5% | -$2.86K | ﹤0.01% | 620 |
|
|
2023
Q3 | $55K | Buy |
776
+36
| +5% | +$2.69K | ﹤0.01% | 588 |
|
|
2023
Q2 | $57K | Sell |
740
-116
| -14% | -$8.98K | ﹤0.01% | 556 |
|
|
2023
Q1 | $64K | Buy |
856
+30
| +4% | +$2.23K | ﹤0.01% | 546 |
|
|
2022
Q4 | $65K | Sell |
826
-3,224
| -80% | -$242K | ﹤0.01% | 574 |
|
|
2022
Q3 | $284K | Buy |
4,050
+28
| +0.7% | +$2.2K | 0.02% | 323 |
|
|
2022
Q2 | $322K | Buy |
4,022
+20
| +0.5% | +$1.56K | 0.02% | 298 |
|
|
2022
Q1 | $303K | Buy |
4,002
+227
| +6% | +$18K | 0.02% | 305 |
|
|
2021
Q4 | $322K | Buy |
3,775
+45
| +1% | +$3.51K | 0.02% | 302 |
|
|
2021
Q3 | $282K | Sell |
3,730
-475
| -11% | -$37.7K | 0.02% | 306 |
|
|
2021
Q2 | $342K | Buy |
4,205
+19
| +0.5% | +$1.55K | 0.02% | 286 |
|
|
2021
Q1 | $330K | Buy |
4,186
+3,033
| +263% | +$238K | 0.02% | 285 |
|
|
2020
Q4 | $99K | Buy |
1,153
+2
| +0.2% | +$165 | 0.01% | 313 |
|
|
2020
Q3 | $89K | Buy |
1,151
+2
| +0.2% | +$152 | 0.01% | 328 |
|
|
2020
Q2 | $84K | Buy |
1,149
+3
| +0.3% | +$213 | 0.01% | 293 |
|
|
2020
Q1 | $76K | Buy |
1,146
+2
| +0.2% | +$141 | 0.01% | 285 |
|
|
2019
Q4 | $79K | Buy |
1,144
+2
| +0.2% | +$136 | 0.01% | 334 |
|
|
2019
Q3 | $83K | Buy |
1,142
+849
| +290% | +$61.6K | 0.01% | 306 |
|
|
2019
Q2 | $21K | Buy |
+293
| New | +$20.8K | ﹤0.01% | 454 |
|
|
2017
Q4 | – | Sell |
-123
| Closed | -$9K | – | 449 |
|
|
2017
Q3 | $9K | Buy |
+123
| New | +$8.87K | ﹤0.01% | 390 |
|
Other funds holding CL
Capital Analysts LLC's CL Position: Q2 2026 in Review
Capital Analysts LLC reduced its Colgate-Palmolive (CL) stake by 4.1% in Q2 2026, selling an estimated $525 and leaving 139 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1242.
Capital Analysts LLC first reported a position in CL in Q3 2017 and has held it in 30 quarters since. The position peaked at $342K in Q2 2021. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Capital Analysts LLC held 139 shares of Colgate-Palmolive worth $13K as of Q2 2026.
- Capital Analysts LLC sold 6 Colgate-Palmolive shares in Q2 2026, an estimated $525.
- Colgate-Palmolive made up ﹤0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #1242 holding.
- Capital Analysts LLC first reported a position in Colgate-Palmolive in Q3 2017 and has held it in 30 quarters since.
- Capital Analysts LLC's Colgate-Palmolive position peaked at $342K in Q2 2021.
- 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.